tiprankstipranks
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
US Market
ANIP
ANI Pharmaceuticals
RESEARCH TOOLSreports
Want to see ANIP full AI Analyst Report?

ANI Pharmaceuticals (ANIP) Income Statement

362 Followers

ANI Pharmaceuticals Income Statement

Last quarter (Q4 2025), ANI Pharmaceuticals's total revenue was $247.06M, an increase of 29.64% from the same quarter last year. In Q4, ANI Pharmaceuticals's net income was $27.49M. See ANI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 883.37M$ 614.38M$ 486.82M$ 316.38M$ 216.14M
Gross Profit
$ 450.64M$ 364.17M$ 305.30M$ 177.60M$ 115.53M
Operating Expenses
$ 369.41M$ 363.58M$ 258.33M$ 212.88M$ 155.32M
Depreciation and Amortization
$ 91.42M$ 67.73M$ 59.79M$ 59.65M$ 47.25M
EBITDA
$ 207.27M$ 63.12M$ 106.60M$ 25.04M$ 3.12M
Operating Income
$ 81.23M$ 584.00K$ 46.97M$ -35.28M$ -39.79M
Other Income/Expenses
$ 14.56M$ -22.80M$ -27.10M$ -27.38M$ -16.27M
Pretax Income
$ 95.79M$ -22.21M$ 19.87M$ -62.66M$ -56.06M
Net Income
$ 78.34M$ -18.52M$ 18.78M$ -47.90M$ -42.60M
Per Share Metrics
Basic EPS
$ 3.50$ -1.04$ 0.95$ -3.05$ -3.40
Diluted EPS
$ 3.32$ -1.04$ 0.94$ -3.05$ -3.40
Weighted Average Shares Outstanding
 20.05M 19.32M 18.00M 16.26M 12.60M
Weighted Average Shares Outstanding (Diluted)
 21.23M 19.32M 18.19M 16.26M 12.60M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History